Market revenue in 2023 | USD 5.9 million |
Market revenue in 2030 | USD 13.6 million |
Growth rate | 12.7% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 79.66% in 2023. Horizon Databook has segmented the Spain mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of the Spanish market is driven by technological advancements and rising awareness about new advanced miRNA sequencing techniques among the end users. Furthermore, various government and nongovernment organizations are actively involved in creating awareness among end users. For instance, the Centre for Genomic Regulation (CRG) is a global biomedical research institute.
This institute is a nonprofit foundation financed by the Spanish Ministry of Science & Innovation the Catalan Government through the Department of Business & Knowledge and the Department of Health, the la Caixa Banking Foundation.
Furthermore, the National Centre for Genomic Analysis (CNAG-CRG), a nonprofit organization supported by the Spanish Ministry of Economic Affairs & Digital Transformation, is also funded by the Catalan Government through the Economy and Knowledge Department and the Health Department.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain mirna sequencing and assay market , including forecasts for subscribers. This country databook contains high-level insights into Spain mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account